Cargando…

Breast cancer recurrence prediction with ensemble methods and cost-sensitive learning

Breast cancer is one of the most common cancers in women all over the world. Due to the improvement of medical treatments, most of the breast cancer patients would be in remission. However, the patients have to face the next challenge, the recurrence of breast cancer which may cause more severe effe...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Pei-Tse, Wu, Wen-Shuo, Wu, Chia-Chun, Shih, Yi-Nuo, Hsieh, Chung-Ho, Hsu, Jia-Lien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122465/
https://www.ncbi.nlm.nih.gov/pubmed/34027105
http://dx.doi.org/10.1515/med-2021-0282
_version_ 1783692625450106880
author Yang, Pei-Tse
Wu, Wen-Shuo
Wu, Chia-Chun
Shih, Yi-Nuo
Hsieh, Chung-Ho
Hsu, Jia-Lien
author_facet Yang, Pei-Tse
Wu, Wen-Shuo
Wu, Chia-Chun
Shih, Yi-Nuo
Hsieh, Chung-Ho
Hsu, Jia-Lien
author_sort Yang, Pei-Tse
collection PubMed
description Breast cancer is one of the most common cancers in women all over the world. Due to the improvement of medical treatments, most of the breast cancer patients would be in remission. However, the patients have to face the next challenge, the recurrence of breast cancer which may cause more severe effects, and even death. The prediction of breast cancer recurrence is crucial for reducing mortality. This paper proposes a prediction model for the recurrence of breast cancer based on clinical nominal and numeric features. In this study, our data consist of 1,061 patients from Breast Cancer Registry from Shin Kong Wu Ho-Su Memorial Hospital between 2011 and 2016, in which 37 records are denoted as breast cancer recurrence. Each record has 85 features. Our approach consists of three stages. First, we perform data preprocessing and feature selection techniques to consolidate the dataset. Among all features, six features are identified for further processing in the following stages. Next, we apply resampling techniques to resolve the issue of class imbalance. Finally, we construct two classifiers, AdaBoost and cost-sensitive learning, to predict the risk of recurrence and carry out the performance evaluation in three-fold cross-validation. By applying the AdaBoost method, we achieve accuracy of 0.973 and sensitivity of 0.675. By combining the AdaBoost and cost-sensitive method of our model, we achieve a reasonable accuracy of 0.468 and substantially high sensitivity of 0.947 which guarantee almost no false dismissal. Our model can be used as a supporting tool in the setting and evaluation of the follow-up visit for early intervention and more advanced treatments to lower cancer mortality.
format Online
Article
Text
id pubmed-8122465
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher De Gruyter
record_format MEDLINE/PubMed
spelling pubmed-81224652021-05-21 Breast cancer recurrence prediction with ensemble methods and cost-sensitive learning Yang, Pei-Tse Wu, Wen-Shuo Wu, Chia-Chun Shih, Yi-Nuo Hsieh, Chung-Ho Hsu, Jia-Lien Open Med (Wars) Research Article Breast cancer is one of the most common cancers in women all over the world. Due to the improvement of medical treatments, most of the breast cancer patients would be in remission. However, the patients have to face the next challenge, the recurrence of breast cancer which may cause more severe effects, and even death. The prediction of breast cancer recurrence is crucial for reducing mortality. This paper proposes a prediction model for the recurrence of breast cancer based on clinical nominal and numeric features. In this study, our data consist of 1,061 patients from Breast Cancer Registry from Shin Kong Wu Ho-Su Memorial Hospital between 2011 and 2016, in which 37 records are denoted as breast cancer recurrence. Each record has 85 features. Our approach consists of three stages. First, we perform data preprocessing and feature selection techniques to consolidate the dataset. Among all features, six features are identified for further processing in the following stages. Next, we apply resampling techniques to resolve the issue of class imbalance. Finally, we construct two classifiers, AdaBoost and cost-sensitive learning, to predict the risk of recurrence and carry out the performance evaluation in three-fold cross-validation. By applying the AdaBoost method, we achieve accuracy of 0.973 and sensitivity of 0.675. By combining the AdaBoost and cost-sensitive method of our model, we achieve a reasonable accuracy of 0.468 and substantially high sensitivity of 0.947 which guarantee almost no false dismissal. Our model can be used as a supporting tool in the setting and evaluation of the follow-up visit for early intervention and more advanced treatments to lower cancer mortality. De Gruyter 2021-05-13 /pmc/articles/PMC8122465/ /pubmed/34027105 http://dx.doi.org/10.1515/med-2021-0282 Text en © 2021 Pei-Tse Yang et al., published by De Gruyter https://creativecommons.org/licenses/by/4.0/This work is licensed under the Creative Commons Attribution 4.0 International License.
spellingShingle Research Article
Yang, Pei-Tse
Wu, Wen-Shuo
Wu, Chia-Chun
Shih, Yi-Nuo
Hsieh, Chung-Ho
Hsu, Jia-Lien
Breast cancer recurrence prediction with ensemble methods and cost-sensitive learning
title Breast cancer recurrence prediction with ensemble methods and cost-sensitive learning
title_full Breast cancer recurrence prediction with ensemble methods and cost-sensitive learning
title_fullStr Breast cancer recurrence prediction with ensemble methods and cost-sensitive learning
title_full_unstemmed Breast cancer recurrence prediction with ensemble methods and cost-sensitive learning
title_short Breast cancer recurrence prediction with ensemble methods and cost-sensitive learning
title_sort breast cancer recurrence prediction with ensemble methods and cost-sensitive learning
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122465/
https://www.ncbi.nlm.nih.gov/pubmed/34027105
http://dx.doi.org/10.1515/med-2021-0282
work_keys_str_mv AT yangpeitse breastcancerrecurrencepredictionwithensemblemethodsandcostsensitivelearning
AT wuwenshuo breastcancerrecurrencepredictionwithensemblemethodsandcostsensitivelearning
AT wuchiachun breastcancerrecurrencepredictionwithensemblemethodsandcostsensitivelearning
AT shihyinuo breastcancerrecurrencepredictionwithensemblemethodsandcostsensitivelearning
AT hsiehchungho breastcancerrecurrencepredictionwithensemblemethodsandcostsensitivelearning
AT hsujialien breastcancerrecurrencepredictionwithensemblemethodsandcostsensitivelearning